Oxidative stress and antioxidant capacity in sickle cell anaemia patients receiving different treatments and medications for different periods of time Edis Belini JuniorDanilo Grünig Humberto da SilvaClaudia Regina Bonini-Domingos Original Article 27 September 2011 Pages: 479 - 489
Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population Laimutis KucinskasSimonas JuzenasLimas Kupcinskas Original Article 27 September 2011 Pages: 491 - 495
Microscopic examination of bone marrow aspirates in malignant disorders of haematopoiesis—a comparison of two slide preparation techniques Krzysztof LewandowskiAgnieszka ComplakAndrzej Hellmann Original Article Open access 12 October 2011 Pages: 497 - 505
The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura Marie-Luise JohnWalter HitzlerInge Scharrer Original Article 28 December 2011 Pages: 507 - 510
Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia Hyung-Doo ParkSoo Hyun LeeHee-Jin Kim Original Article 08 September 2011 Pages: 511 - 517
IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome Jiang LinDong-ming YaoWen-rong Xu Original Article 14 October 2011 Pages: 519 - 525
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study Esther Natalie OlivaAndrea PiccinSante Tura Original Article 01 October 2011 Pages: 527 - 532
TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms Luz Martínez-AvilésCarlos BessesBeatriz Bellosillo Original Article 09 September 2011 Pages: 533 - 541
Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study Hye Jin KangWon Seog KimBaek-Yeol Ryoo Original Article 16 September 2011 Pages: 543 - 551
Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma Cheng FangDan-Xia ZhuJian-Yong Li Original Article 11 October 2011 Pages: 553 - 559
Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry Stefan W. KrauseMichael GerkenMonika Klinkhammer-Schalke Original Article 28 December 2011 Pages: 561 - 570
DAAM2 polymorphism is closely related to the clinical outcomes of allogeneic hematopoietic stem cell transplantation Hyeon Gyu YiCheng Zhe PiaoSeonyang Park Original Article 10 September 2011 Pages: 571 - 576
Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients Pervin TopcuogluMutlu AratGunhan Gurman Original Article 05 October 2011 Pages: 577 - 586
Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus Yi-Chang LiuPo-Liang LuSheng-Fung Lin Original Article 15 October 2011 Pages: 587 - 595
Cytomegalovirus infection is associated with venous thromboembolism of immunocompetent adults—a case–control study Sven SchimanskiBirgit LinnemannChristian M. Schambeck Original Article 09 September 2011 Pages: 597 - 604
Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a pilot study L. KwofieB. L. RapoportG. R. Tintinger Original Article 06 October 2011 Pages: 605 - 611
Athrombogenic coating of long-term venous catheter for cancer patients: a prospective, randomised, double-blind trial Felicitas HitzDirk KlingbielThomas Cerny Original Article 29 September 2011 Pages: 613 - 620
Successful management with an effective induction regimen followed by allogeneic hematopoietic stem cell transplantation for promyelocytic blast crisis of chronic myelogenous leukemia Bo CaiWeidong YangChunji Gao Letter to the Editor 04 June 2011 Pages: 621 - 623
Liver failure as the only clinical manifestation of multiple myeloma David CoffeyBrandon FainSamia Nawaz Letter to the Editor 06 July 2011 Pages: 625 - 627
Effects of tamibarotene for the treatment of adult T cell leukemia Yasuhiro MaedaMasaya KawauchiItaru Matsumura Letter to the Editor 01 July 2011 Pages: 629 - 631
Are int22h-mediated deletions a common cause of hemophilia? Miguel Martín AbelleyroLiliana Carmen RossettiCarlos Daniel De Brasi Letter to the Editor 20 July 2011 Pages: 633 - 636
Chronic myeloproliferative disorder with ETV6-PDGFRβ fusion gene Eswar TipirneniAmanpreet ButtarVenu Bathini Letter to the Editor 22 July 2011 Pages: 637 - 638
Treatment for orbital diffuse large B-cell lymphoma in an elderly patient by autologous cytokine-induced killer cells Su-Xia LiHong-Li ZhuShan-Qian Yao Letter to the Editor 19 August 2011 Pages: 639 - 640
Diagnostic and therapeutic challenges of severe Rh e-specific IgA-mediated autoimmune hemolytic anemia Leonie A. BovenAmy de Haar-HollemanRob Fijnheer Letter to the Editor 30 July 2011 Pages: 641 - 642
Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine Seah H. LimSrinivas PathapatiAndrew Hoot Letter to the Editor 03 August 2011 Pages: 643 - 644
